Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
154-160
Author(s):
Benjamin Purow
Targeting the Immune System in Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
166-184
Author(s):
Devyani Chaudhuri, Robert Suriano, Abraham Mittelman and Raj K. Tiwari
Novel Classes of Dimer Antitumour Drug Candidates
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
659-674
Author(s):
Larry M.C. Chow and Tak Hang Chan
Pleiotropic Effects of Fenofibrate
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
517-528
Author(s):
V. Tsimihodimos, E. Liberopoulos and M. Elisaf
Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
394-416
Author(s):
Roger Besancon, Sandrine Valsesia-Wittmann, Alain Puisieux, Claude Caron de Fromentel and Veronique Maguer-Satta
Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
411-421
Author(s):
C. Uchida and T. L. Haas
Targeting Histone Deacetylases in Neuroblastoma
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
436-447
Author(s):
O. Witt, H. E. Deubzer, M. Lodrini, T. Milde and I. Oehme
Genome and Transcriptome Analysis of Neuroblastoma Advanced Diagnosis from Innovative Therapies
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
448-455
Author(s):
S. Coco, G. P. Tonini, S. Stigliani and P. Scaruffi
MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
456-462
Author(s):
R. L. Stallings
Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
162-184
Author(s):
Jose J.G. Marin, Marta R. Romero, Alba G. Blazquez, Elisa Herraez, Emma Keck and Oscar Briz